The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we have you know just reams of data now of using mtor inhibitors to enhance immune function and older people safety data and data on incidents severity of respiratory tract infections and a lot of biomarker data to start understanding what is actually going on in the immune system
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
what it looked like is just turning mtor down in the elderly not turning it off is the best for enhancing immune function